fIPV-dmLT (University of Vermont)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamefIPV-dmLT (University of Vermont)

Drug Alias Namefractional-dose inactivated vaccine with dmLT adjuvant(University of Vermont)

ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsPoliomyelitis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Vermont

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Vermont

Inactive CompaniesN/A

Active IndicationsPoliomyelitis

Inactive IndicationsN/A

Other Information

ATC CodeN/A